Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SCHERING-PLOUGH INTRODUCING FOUR LOTRIMIN AF LINE EXTENSIONS

This article was originally published in The Tan Sheet

Executive Summary

SCHERING-PLOUGH INTRODUCING FOUR LOTRIMIN AF LINE EXTENSIONS as part of the second stage of the company's strategic plan to revamp its over-the-counter foot care business. In addition to four new Lotrimin AF products, Schering-Plough is introducing 18 new Dr. Scholl's products. The roll out of the 22 new OTC foot care products to the trade began on Feb. 14. Schering-Plough said it expects the products to be available nationwide by mid-April.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082539

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel